News | Hypertension | September 14, 2017

Marijuana Associated With Three-Fold Risk of Death From Hypertension

Study also found that hypertension death risk increased with each additional year of marijuana use

Marijuana Associated With Three-Fold Risk of Death From Hypertension

September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently in the European Journal of Preventive Cardiology.

“Steps are being taken towards legalization and decriminalization of marijuana in the United States, and rates of recreational marijuana use may increase substantially as a result,” said lead author Barbara A. Yankey, a Ph.D. student in the School of Public Health, Georgia State University, Atlanta. “However, there is little research on the impact of marijuana use on cardiovascular and cerebrovascular mortality.”

In the absence of longitudinal data on marijuana use, the researchers designed a retrospective follow-up study of NHANES (National Health and Nutrition Examination Survey) participants aged 20 years and above. In 2005–2006, participants were asked if they had ever used marijuana. Those who answered “yes” were considered marijuana users. Participants reported the age when they first tried marijuana and this was subtracted from their current age to calculate the duration of use.

Information on marijuana use was merged with mortality data in 2011 from the National Centre for Health Statistics. The researchers estimated the associations of marijuana use, and duration of use, with death from hypertension, heart disease and cerebrovascular disease, controlling for cigarette use and demographic variables including sex, age and ethnicity. Death from hypertension included multiple causes such as primary hypertension and hypertensive renal disease.

Among a total of 1,213 participants, 34 percent used neither marijuana nor cigarettes, 21 percent used only marijuana, 20 percent used marijuana and smoked cigarettes, 16 percent used marijuana and were past-smokers, 5 percent were past-smokers and 4 percent only smoked cigarettes. The average duration of marijuana use was 11.5 years.

Marijuana users had a higher risk of dying from hypertension. Compared to non-users, marijuana users had a 3.42-times higher risk of death from hypertension and a 1.04 greater risk for each year of use. There was no association between marijuana use and death from heart disease or cerebrovascular disease.

Yankey said: “We found that marijuana users had a greater than three-fold risk of death from hypertension and the risk increased with each additional year of use.”

Yankey pointed out that there were limitations to the way marijuana use was estimated. For example, it cannot be certain that participants used marijuana continuously since they first tried it.

She said: “Our results suggest a possible risk of hypertension mortality from marijuana use. This is not surprising since marijuana is known to have a number of effects on the cardiovascular system. Marijuana stimulates the sympathetic nervous system, leading to increases in heart rate, blood pressure and oxygen demand. Emergency rooms have reported cases of angina and heart attacks after marijuana use.”

The authors stated that the cardiovascular risk associated with marijuana use may be greater than the cardiovascular risk already established for cigarette smoking.

“We found higher estimated cardiovascular risks associated with marijuana use than cigarette smoking,” said Yankey. “This indicates that marijuana use may carry even heavier consequences on the cardiovascular system than that already established for cigarette smoking. However, the number of smokers in our study was small and this needs to be examined in a larger study.”

“Needless to say, the detrimental effects of marijuana on brain function far exceed that of cigarette smoking,” she added.

Yankey said it was crucial to understand the effects of marijuana on health so that policy makers and individuals could make informed decisions.

She said: “Support for liberal marijuana use is partly due to claims that it is beneficial and possibly not harmful to health. With the impending increase in recreational marijuana use it is important to establish whether any health benefits outweigh the potential health, social and economic risks. If marijuana use is implicated in cardiovascular diseases and deaths, then it rests on the health community and policy makers to protect the public.”

For more information: www.journals.sagepub.com/home/cpr

Related Content

Marijuana Use Associated With Increased Risk of Stroke, Heart Failure

Secondhand Marijuana Smoke May Damage Blood Vessels as Much as Tobacco Smoke

 

References

Yankey BA, et al. Effect of marijuana use on cardiovascular and cerebrovascular mortality: A study using the National Health and Nutrition Examination Survey linked mortality file. European Journal of Preventive Cardiology. 2017. DOI: 10.1177/2047487317723212


Related Content

News | Hypertension

Sept. 04, 2025 — CorVista Health has published a new case series in the Journal of the American College of Cardiology ...

Home September 09, 2025
Home
News | Hypertension

Sept. 5, 2025 — Idorsia Ltd has announced a first-of-its-kind initiative with the Stanford Hypertension Center and Duke ...

Home September 08, 2025
Home
News | Hypertension

Aug. 19, 2025 — Idorsia Ltd recently announced its novel dual endothelin receptor antagonist (ERA), Tryvio (aprocitentan ...

Home August 27, 2025
Home
News | Hypertension

May 19, 2025 — Gradient Denervation Technologies recently announced the company’s pulmonary denervation system has ...

Home May 20, 2025
Home
News | Hypertension

April 9, 2025 — Idorsia Ltd recently announced that the US Food & Drug Administration (FDA), after having released ...

Home April 09, 2025
Home
News | Hypertension

Mar. 10, 2025-- Corcept Therapeutics Inc., a commercial-stage company engaged in the discovery and development of ...

Home March 11, 2025
Home
News | Hypertension

Jan. 9, 2025 — Gender-based racism through microaggressions may be linked to higher blood pressure postpartum and beyond ...

Home January 14, 2025
Home
News | Hypertension

Jan. 8, 2025 — Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing medicines ...

Home January 08, 2025
Home
News | Hypertension

Dec. 11, 2024 — Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking ...

Home December 19, 2024
Home
News | Hypertension

June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative ...

Home June 28, 2024
Home
Subscribe Now